Agoracom: Small Cap Investment - Valeo Pharma Inc. - Digital Investor Awareness Program-VPH

A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Reply New Message

Back To Forum List View

kooter33

Rank: Treasurer [?]

Points: 4017 [?]

Votes: 147 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Digital Investor Awareness Program-VPH

posted on Dec 09, 2020 01:05PM

This is a great company to follow. Glad to see they are moving forward with this digital investor awareness program. There is so much potential here IMO. Stellar management team with a proven track record and flawless business model. They are expected to be EBDITA positive for the new FY. Which started in Nov 2020. Adding Redesca (LMWH) to the portfolio of Health Canada approved and proven drugs, the future never look brighter for Valeo Pharma. This is a stellar company with huge growth potential. I am a buyer and have been for months.